Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Clinical Chemistry

• Publication date

  1994-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CLINCHEM/40.8.1631PMID 8045021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis.

  1994cited by this paper
• Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy.

  1993cited by this paper
• Markov Models in Medical Decision Making

  1993cited by this paper
• Screening for hemochromatosis.

  1993cited by this paper
• The cost‐effectiveness of preoperative autologous blood donation for total hip and knee replacement

  1993cited by this paper
• Cost‐effectiveness of white cell‐reduction filters in treatment of adult acute myelogenous leukemia

  1993cited by this paper
• Long-term survival analysis in hereditary hemochromatosis.

  1991cited by this paper
• A clinician's guide to cost-effectiveness analysis.

  1990cited by this paper
• Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.

  1988cited by this paper
• Laboratory decision science applied to chemometrics: strategic testing of thyroid function.

  1986cited by this paper
• A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

  1982cited by this paper
• A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method.

  1982cited by this paper
• Perspectives in iron metabolism.

  1982cited by this paper
• Hereditary hemochromatosis: contributions of genetic analyses.

  1981cited by this paper
• Serum-ferritin in diagnosis of haemochromatosis. A study of 43 families.

  1977cited by this paper
• Foundations of cost-effectiveness analysis for health and medical practices.

  1977cited by this paper

• Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review

  2024influential citation
• Effectiveness, stabilization, and potential feasible analysis of a biochar material on simultaneous remediation and quality improvement of vanadium contaminated soil

  2020cites this paper
• Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study.

  2017cites this paper
• The Health Economics of Haemochromatosis

  2016cites this paper
• A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis

  2015influential citation
• Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable to the general population

  2012cites this paper
• Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population

  2011cites this paper
• Chapter 14 – Evaluation of Abnormal Liver Tests

  2010cites this paper
• The Cost-Effectiveness of Screening for Hereditary Hemochromatosis in Germany: A Remodeling Study

  2009cites this paper
• Arvelig hemokromatose - nytten av screening

  2009influential citation
• Simulation du ratio coût-efficacité des scénarios de dépistage de l'hémochromatose

  2007cites this paper
• Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study

  2005cites this paper
• Screening Primary Care Patients for Hereditary Hemochromatosis with Transferrin Saturation and Serum Ferritin Level: Systematic Review for the American College of Physicians

  2005cites this paper
• A critical review of personnel standards

  2004cites this paper
• Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortality.

  2002cites this paper
• Strategies for early diagnosis of haemochromatosis

  2002cites this paper
• Benefit of Population-based Screening for Phenotypic Hemochromatosis in Young Men

  2002influential citation
• Hemochromatosis Detection in a Health Screening Program at an Alabama Forest Products Mill

  2002cites this paper
• Total Iron Binding Capacity and Transferrin Concentration in the Assessment of Iron Status

  2002cites this paper
• Screening for Hemochromatosis: High Prevalence and Low Morbidity in an Unselected Population of 65,238 Persons

  2001cites this paper
• What is the role of genetic testing in diagnosis of haemochromatosis?

  2001cites this paper
• guidelines British Committee for Standards in Haematology Guidelines on diagnosis and therapy British Society for Haematology Genetic Haemochromatosis

  2001cites this paper
• [Iron overload and public health].

  2000cites this paper
• Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions.

  2000cites this paper
• Early Detection of Genetic Hemochromatosis: Should All Young Adults Be Offered the Genetic Test?

  2000cites this paper
• Hémochromatose

  2000cites this paper
• Cost-Effectiveness of Population-Based Genetic Hemochromatosis Screening

  2000cites this paper
• Deciding when to intervene: a Markov decision process approach

  2000cites this paper
• [Hemochromatosis].

  2000cites this paper
• Wellness assessment: A role for laboratory medicine.

  2000cites this paper
• Hereditary haemochromatosis: diagnosis and management in the gene era.

  1999cites this paper
• Hereditary hemochromatosis: impact of molecular and iron-based testing on the diagnosis, treatment, and prevention of a common, chronic disease.

  1999cites this paper
• Screening for hemochromatosis. A public health perspective.

  1999cites this paper
• Evaluation of a workplace hemochromatosis screening program.

  1999cites this paper
• Screening for Hemochromatosis in Primary Care Settings

  1998cites this paper
• Prevalence of Elevated Serum Transferrin Saturation in Adults in the United States

  1998cites this paper
• Taking a count: the evaluation of genetic testing

  1998cites this paper
• Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening

  1998cites this paper
• Hemochromatosis: new insights in pathogenesis and diagnosis following the discovery of the gene.

  1998cites this paper
• Screening for hemochromatosis: phenotype versus genotype.

  1998cites this paper
• Screening for Hemochromatosis and Iron Deficiency in Employees and Primary Care Patients in Western Germany

  1998cites this paper
• [Should we screen for hemochromatosis? Critical analysis of the literature].

  1997cites this paper
• Iron, HFE, and Hemochromatosis Update

  1997cites this paper
• Mild liver enzyme abnormalities: eliminating hemochromatosis as cause.

  1997influential citation
• The complex connections between test properties and relevant outcomes: widening the perspective.

  1997cites this paper
• Hereditary hemochromatosis.

  1997cites this paper
• Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis.

  1996cites this paper
• Abdominal iron deposition: metabolism, MR findings, and clinical importance.

  1996cites this paper
• Genetic hemochromatosis: pathogenesis, diagnosis, and therapy.

  1996cites this paper
• A critical review of personnel standards.

  1996cites this paper
• Elevation of serum ferritin is superior to fecal occult blood testing as a screening test for colonic adenoma … and not only because patients do not have to handle their own stool

  1996cites this paper
• Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database.

  1995cites this paper